Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
, 13 (4), 237-9

[Barbiturate Withdrawal Syndrome: A Case Associated With the Abuse of a Headache Medication]

[Article in Italian]
Affiliations
  • PMID: 10349206
Case Reports

[Barbiturate Withdrawal Syndrome: A Case Associated With the Abuse of a Headache Medication]

[Article in Italian]
C Sarrecchia et al. Ann Ital Med Int.

Abstract

Barbiturates can produce psychological and physical dependence and produce a withdrawal syndrome on the second to fourth day after the drug is suspended. Symptoms include anxiety, restlessness, insomnia, rhythmic intention tremor, dizziness, seizures, and psychosis. If the syndrome is not recognized and correctly treated, hyperthermia, circulatory failure, and death may ensue. Although barbiturates are less frequently used nowadays, they are employed in combination with other drugs in many medications used for the treatment of headache. We report the case of a 54-year-old woman who developed a barbiturate abstinence syndrome when she suspended self-administration of a drug containing butalbital. The patient had been using barbiturates, 900 mg/die, for 2+ years for persistent headache. She was admitted to the hospital because of seizures, hallucinations and delirium not controlled by benzodiazepine and phenothiazine administration. Her symptoms resolved after parenteral phenobarbital administration.

Similar articles

  • Barbiturate Withdrawal Following Internet Purchase of Fioricet
    CE Romero et al. Arch Neurol 61 (7), 1111-2. PMID 15262744. - Case Reports
    The withdrawal state from barbiturates is similar to that from ethanol. Tolerance can develop with prolonged abuse, leading to escalating drug doses to achieve the desire …
  • Gamma-hydroxybutyrate Withdrawal Syndrome
    JE Dyer et al. Ann Emerg Med 37 (2), 147-53. PMID 11174231. - Case Reports
    In our patients, severe GHB dependence followed frequent ingestion every 1 to 3 hours around-the-clock. The withdrawal syndrome was accompanied initially by symptoms of a …
  • Treatment of the Barbiturate Abstinence Syndrome
    JT Sullivan et al. Med J Aust 145 (9), 456-8. PMID 3773832.
    Patients with the barbiturate abstinence syndrome require pharmacotherapy (and hospitalization) when there is a history of the ingestion of greater than 0.4 g of secobarb …
  • [Analgesic-induced Chronic Headache]
    C Le Jeunne. Ann Med Interne (Paris) 152 Suppl 3, IS50-3. PMID 11435995. - Review
    Analgesic-induced chronic headaches are the outcome of an overtreatment of migraine or tension type headaches. Progressively, the usual headache changes and becomes a chr …
  • Risk of Drug Dependence and Abuse Posed by Barbiturate-Containing Analgesics
    EM Sellers et al. Can J Clin Pharmacol 6 (1), 18-25. PMID 10465862. - Review
    Concern has been raised that the barbiturate component of barbiturate-containing analgesics constitutes a public and individual health problem because of information from …
See all similar articles

Cited by 1 PubMed Central articles

MeSH terms

LinkOut - more resources

Feedback